Drug class in one race
Tissue Factor (TF) drugs for Non-Small Cell Lung Cancer
2 tracked Tissue Factor (TF) drugs in the Non-Small Cell Lung Cancer race. The class explanation lives on the Tissue Factor (TF) page; the full indication pipeline across every mechanism is on the Non-Small Cell Lung Cancer page.
1 Phase 21 Phase 1
Head-to-head evidence: STRO-004 vs Tisotumab Vedotin Humax-tf-adc